L Staudacher

Publications (1)6.43 Total impact

• Source

  Available from: oxfordjournals.org

  Article: Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery.

  W Cacheux, T Boisserie, L Staudacher, O Vignaux, B Dousset, O Soubrane, B Terris, C Mateus, S Chaussade, F Goldwasser
  Annals of Oncology 10/2008; 19(9):1659-61. · 6.43 Impact Factor